← Eichor
Study identifier: NCT06140719 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

xPedite: A Study to Expedite DIPG and DMG Research

Condition: Oncology · DIPG · DMG  ·  Sponsor: xCures

PhaseN/A
Planned participants400
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

This study will gather data from new and existing patients with patient medical records, and patient/family/caregiver reported information to establish a clear natural history of disease suitable to serve as an external, contemporary or historical control arm for future therapeutic development programs of drugs, devices, or biologic interventions in DMG or DIPG.

This description comes directly from the study's public registry record.

Talk to the study team

xCures Study Team  ·  707-641-4475  ·  navigator@xcures.com

Always discuss trial participation with your own doctor first.

Locations (1)

xCures, Inc.Los Altos, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06140719